OR WAIT null SECS
Industry news focusing on the people and organizations who work in the clinical trials profession.
Bringing with her over 15 years of clinical and research experience, Ravi Pawa, MB ChB, is Synexus' (Lancashire, UK) new medical advisor. Pawa previously served as the company's clinical director of the Lancashire Research Center.
Madeira Therapeutics (Leadwood, KS) has added David Tousley, MBA, CPA, the current principal of Stratium Consulting Services, to the Madeira Board of Advisors.
Tara Webb is ACORN's (Memphis, TN) new senior director of business development, after serving in the same position for i3 Statprobe (Basking Ridge, NJ).
Evette Riegel, RN, will serve as Beardsworth's (Flemington, NJ) project director in clinical operations as of her recent promotion. In this position she will work to expand the company's oncology niche specialty.
Sven Degroeve will serve as MDCPartners' (Brussels, Belgium) new knowledge systems architect, where he will work to strengthen the company's technology and consultancy divisions.
Yong-Xi Li joins the Medpace (Cincinnati, OH) team as the new executive director and brings with him a strong background in bioanalytical technology, method development, validation, and sample analysis in pharmaceutical development.
John Nestor, a medicinal chemist experienced in drug discovery at large pharmaceutical and biotechnology companies, joins Transition Therapeutics (Toronto, Canada) as its new vice president of drug discovery.
Actavis (Hafnarfjordur, Iceland) has made a series of senior appointments including, Gudbjorg Edda Eggersdottir to deputy chief executive officer, Vlaur Ragnarsson to executive vice president of third-party sales, and Doug Boothe to chief executive officer of Actavis, United States.
Upon Michael Griffith's resignation from Aptuit (Greenwich, CT), Timothy Tyson has been appointed as the new executive chairman and acting chief executive officer.
Colleen Pero has been hired as TB Alliance's (New York, NY) new chief administrative officer, where she will be responsible for leading the expansion of the company's staff and internal operations as it advances its drug pipeline.
With over 25 years of pharmaceutical and CRO experience, Deena Wegner will become Drug Safety Alliance's (Research Triangle Park, NC) new vice president of business development and strategy.
Premier Research (Philadelphia, PA) has appointed Fabio Trave, MD, to executive director of medical affairs and strategic product development.
Sam Dranoff, the recent managing director of commercial operations for Biomedical System's (St. Louis, MO), has been promoted to vice president of business development, imaging services.
Guy Dewil, MD, has been appointed ICON's (Dublin, Ireland) new chief operating officer, where he will manage the company's global operations.
ProFibrix (Leiden, The Netherlands) has brought Jan Ohrstrom on board as the company's new chief operating officer, after serving on ZymoGenetics' senior management team.
Nextrials (San Ramon, CA) has appointed Robert Barr to the position of chief technology officer and Michelle Dockhorn as vice president of global sales and marketing.
BT Pharma (Toulouse, France) appointed Professor Thierry Hercend, MD, president of the company's supervisory board, where he will be able to utilize over 30 years of academic and pharmaceutical experience
Xcelience (Tampa, FL) brought four new people on board including, Omar Lamm, Dontae Solomon, and Robert Steitz as associates in business development, and Kim Black-Washington as director of marketing and strategic development.